Quick Overview: Tomas Neilan, MD, MPH Cardiologist Director, Cardio-Oncology Program Co-Director, Watch the full video on Radcliffe Cardiology here: ... Tomas G. Neilan, MD, MPH, MRCPI, FACC Director, Cardio-Oncology Program; co-Director,

Cardiovascular Disease And Immune Checkpoint - Detailed Overview & Context

Tomas Neilan, MD, MPH Cardiologist Director, Cardio-Oncology Program Co-Director, Watch the full video on Radcliffe Cardiology here: ... Tomas G. Neilan, MD, MPH, MRCPI, FACC Director, Cardio-Oncology Program; co-Director, Journal Editor-in-Chief Bonnie Ky, MD, MSCE, FACC, moderates a video case presentation on Early For more information To request credit ... In this Peer Perspectives video, Asia Pulse Content Editors Jeehoon Kang, MD and HyunJin Ahn, MD speak with Wei-Ting Chang ...

Learning Objectives At the conclusion of this activity, participants should be better able to: 1. Understand the expanding role of ... In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with Allan Jaffe, M.D., a consultant in the Department ... Watch Cardiology Grand Rounds from The Texas Hosted by Drs. Reynolds and Neilan. Download resources & collect credit » Lauren A. Baldassarre, MD, FACC, FSCMR, FSCCT, director of the Cardio-Oncology Program at the Yale Cancer Center, focuses ... Researchers have noticed a new clinical syndrome for patients treated with

Han Zhu, MD, Stanford University, Standford, CA, discusses risk factors for cardiotoxic events in patients treated with Medpage Today: Online CME - Continuing medical education: Drs. Kullo and Kopecky talk about why genetic testing is needed in chronic ... Discoveries webinar, Prof Esther Lutgens and Prof Holger Winkels discuss

Photo Gallery

Cardiovascular Disease and Immune Checkpoint Therapy for Cancer
Cardiovascular Toxicity and Immune Checkpoint Inhibitors
CV Impact of Immune Checkpoint Inhibitor Cardiotoxicity
Cardiac Toxicities Among Patients Treated with Immune Checkpoint
JACC: CardioOncology Video Case Presentation | Early Immune Checkpoint Inhibitor Cardiotoxicity
Immune Checkpoint Inhibitor Cardiotoxicity
Cardio-Oncology Series - What Do Immune Checkpoint Inhibitors Do to the Heart? | JACC: Asia Pulse
Acute and Chronic Cardiac and Vascular Effects of Contemporary Immune Therapies for Cancer
Cardiac Troponins and Checkpoint Inhibitors
Discover the critical risks of immune checkpoint inhibitors myocarditis
Anita Deswal, MD, MPH, MBBS | Cardiovascular Effects of Immune Checkpoint Inhibitors for Cancer:...
Immune Checkpoint Inhibitor Cardiotoxicity
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored